Overview

PET Imaging of Brain Amyloid in Normal Pressure Hydrocephalus

Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
This study will determine the level of association between the quantitative estimates of brain uptake of [18F]flutemetamol and the quantitative immunohistochemical estimates of amyloid levels in biopsy samples previously obtained during shunt placement in patients who have normal pressure hydrocephalus (NPH).
Phase:
Phase 3
Details
Lead Sponsor:
GE Healthcare
Collaborator:
i3 Statprobe
Treatments:
Flutemetamol